Bio€quity Europe 2014
21-22 May 2014
Amsterdam, NL
BioEquity Europe 2014, the 15th collaborative gathering of the corporate investment communities for the European life sciences, took place 21–22 May in Amsterdam, NL. The event has been organised by the EBD Group.
Read next in 'Events'
- The 2024 international workshop on Alport syndrome
- ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
- 6th CKD Summit – Chronic Kidney Disease Drug Development
- ASN Kidney Week
- Alport Connect 2023, the annual Alport syndrome patient and family meeting in US